Tang Li, Yu Hongfan, Dai Wei, Yang Xiaojun, Wei Xing, Wang Xin Shelley, Cleeland Charles S, Li Qiang, Shi Qiuling
State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, School of Public Health and Management, Chongqing Medical University, Yuzhong District, Chongqing, 400016, China.
School of Public Health, Chongqing Medical University, Chongqing, China.
Ann Surg Oncol. 2023 May;30(5):2607-2617. doi: 10.1245/s10434-022-13065-z. Epub 2023 Jan 19.
Application of patient-reported outcomes (PROs) in surgical oncology has been limited because of patient heterogeneity. We analyzed symptom trajectories and their associations with recovery outcomes after lung cancer surgery, aiming to profile the heterogeneity of patients' experiences and to identify patients needing extensive care.
Symptoms were assessed with the MDASI-LC before surgery, daily after surgery in hospital and weekly within 1 month after discharge. Patients were clustered based on symptoms from post-operative day 1 (POD1) to POD5, using the latent-class-trajectory-model. Functional recovery was compared across the trajectories. Logistic regression was used to explore risk factors for trajectories of more severe symptoms.
Based on the five most severe post-surgery symptoms (pain, fatigue, coughing, shortness of breath, and disturbed sleep), we identified three distinct symptom trajectories among 424 patients [mild, N = 225 (53.07%); severe-to-mild, N = 86 (20.28%); severe, N = 104 (24.53%)]. At discharge, more 'severe' patients (73.96%) did not achieve a functional recovery compared with those in mild (32.54%, P < 0.0001) or severe-to-mild (56.96%, P = 0.0274) groups. Factors of significant symptom increase on POD1 were younger-than-55 (OR = 1.94 [95% CI 1.30-2.93], P = 0.001), undergoing open or multi-port video-assisted thoracoscopic surgery (OR = 1.59 [95% CI 1.05-2.41], P = 0.03), and using two chest tubes (OR = 1.72 [95% CI 1.12-2.65], P = 0.01). For patients experiencing dramatic symptom increase on POD1, older age (OR = 2.51 [95% CI 1.40-4.59], P = 0.002) was associated with 'severe' trajectory.
This study demonstrated that PRO measures were capable of profiling heterogeneous symptom trajectories after lung cancer surgery. Those in-hospital trajectories were able to differentiate patients' responses to treatments and signal the needs for extensive post-discharge care.
由于患者的异质性,患者报告结局(PROs)在外科肿瘤学中的应用一直受到限制。我们分析了肺癌手术后的症状轨迹及其与恢复结局的关联,旨在描述患者体验的异质性,并识别需要长期护理的患者。
在手术前、术后住院期间每日以及出院后1个月内每周使用肺癌MDASI评估症状。使用潜在类别轨迹模型,根据术后第1天(POD1)至第5天的症状对患者进行聚类。比较各轨迹的功能恢复情况。采用逻辑回归分析更严重症状轨迹的危险因素。
基于术后最严重的五种症状(疼痛、疲劳、咳嗽、呼吸急促和睡眠障碍),我们在424例患者中识别出三种不同的症状轨迹[轻度,N = 225例(53.07%);重度至轻度,N = 86例(20.28%);重度,N = 104例(24.53%)]。出院时,与轻度组(32.54%,P < 0.0001)或重度至轻度组(56.96%,P = 0.0274)相比,更多“重度”患者(73.96%)未实现功能恢复。POD1症状显著增加的因素包括年龄小于55岁(OR = 1.94 [95% CI 1.30 - 2.93],P = 0.001)、接受开胸或多端口电视辅助胸腔镜手术(OR = 1.59 [95% CI 1.05 - 2.41],P = 0.03)以及使用两根胸管(OR = 1.72 [95% CI 1.12 - 2.65],P = 0.01)。对于POD1症状急剧增加的患者,年龄较大(OR = 2.51 [95% CI 1.40 - 4.59],P = 0.002)与“重度”轨迹相关。
本研究表明,PRO测量能够描绘肺癌手术后异质性的症状轨迹。这些住院期间的轨迹能够区分患者对治疗的反应,并表明出院后需要长期护理。